S 9279 New York Senate · 2025 Regular Session

Relates to the operation of gene synthesis providers and manufacturers of gene synthesis equipment

Summary

Requires gene synthesis providers and manufacturers of gene synthesis equipment to operate in accordance with rules and regulations issued by the department of health, including identifying potentially dangerous sequences and maintaining certain records.

Bill status in committee 1 of 4 stages cleared

Introduction

Feb 2026

Committee Review

Floor Vote

Governor

Introduced Feb 24, 2026 Last action Jun 2, 2026

Maddy AI version diff · 1 comparison

What changed between versions

S9279 → S9279A · 3 edits

MINOR

The bill was amended to add a new section requiring the health department to issue specific regulations for gene synthesis providers, including rules to identify dangerous genetic sequences and screen customers. The effective date of the law was changed from immediate to ninety days after enactment to allow time for these new rules to be developed.

Scope change

The bill's scope was expanded to explicitly mandate the creation of regulations regarding dangerous genetic sequences and customer screening, which were previously absent from the text.

REQUIREMENT

Added a requirement for the health department to issue regulations specifically covering the identification of potentially dangerous genetic sequences and the screening of potential customers.

Added a requirement for the health department to retain records of genes synthesized and delivered.

TIMELINE

Changed the effective date of the act from 'immediately' to 'ninetieth day after it shall have become a law'.

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Amendments

Mar 13, 2026

Upper · Passed

PRINT NUMBER 9279A

upper

Mar 13, 2026

Upper · Passed

AMEND AND RECOMMIT TO HEALTH

upper

Feb 24, 2026

Committee

REFERRED TO HEALTH

upper

1 primary · 0 co-sponsors